Adjuvant Melatonin for Uveal Melanoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 2, 2022

Primary Completion Date

January 1, 2031

Study Completion Date

January 1, 2031

Conditions
Uveal MelanomaUveal Melanoma, Posterior, Medium/Large SizeEye Cancer, Intraocular Melanoma
Interventions
DRUG

Melatonin

White round tablets, each with a dose of 5 mg Melatonin. 4 tablets taken simultaneously at night. Tablets can be crushed and/or taken with a glass of water if the patient wish.

Trial Locations (1)

17164

RECRUITING

St. Erik Eye Hospital, Stockholm

All Listed Sponsors
collaborator

Karolinska Trial Alliance

INDUSTRY

collaborator

The Swedish Eye Foundation (Ögonfonden)

UNKNOWN

collaborator

The Swedish Society of Medicine

OTHER

collaborator

Swedish Cancer Foundation

OTHER

lead

Gustav Stalhammar

OTHER